Table 4.
patient S/N | visits | ATD dosage (mg) | review interval (day) | actual FT4 (pmol l−1) | predicted FT4 (pmol l−1) |
---|---|---|---|---|---|
2 | 1st | 0 | 0 | 75 | — |
2 | 2nd | 30 | 77 | 13 | 11.9 |
2 | 3rd | 15 | 28 | 7 | 13.9 |
2 | 4th | 10 | 168 | 16 | 14.8 |
2 | 5th | 5 | 168 | 15 | 16.0 |
2 | 6th | 5 | 91 | 15 | 16.0 |
2 | 7th | 0 | 98 | 25 | 17.3 |
2 | 8th | 5 | 84 | 13 | 16.0 |
2 | 9th | 5 | 203 | 13 | 16.0 |
16 | 1st | 0 | 0 | 14 | — |
16 | 2nd | 15 | 90 | 13 | 11.6 |
16 | 3rd | 17.5 | 78 | 10 | 11.3 |
23 | 1st | 0 | 0 | 40 | — |
23 | 2nd | 15 | 35 | 16 | 12.1 |
23 | 3rd | 15 | 84 | 10 | 12.1 |
23 | 4th | 7.5 | 84 | 13 | 14.2 |